David Spigel, MD, discusses the significant benefits of durvalumab as consolidation therapy following standard ...

ST-001, an intravenous nanoformulation of fenretinide, will be evaluated in a phase 1a/1b small cell lung cancer trial.

In a small study, lactotransferrin (LTF) was identified as a potentially important biomarker in extensive-stage small cell ...

The Chamber of Commerce of West Alabama’s Adopt-A-School Program connects local businesses and organizations with schools in ...

Limited’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Several weeks ago, one church from Georgia made their way to Alabama to see and understand the African-American history that ...

An exploratory analysis shows a reduction in extrathoracic metastases and prolonged time to progression or death due to any ...

The poster presented data from AUTX-703, a potent, selective and orally bioavailable heterobifunctional degrader of KAT2A/B, an AURIGIN-identified histone acetyltransferase driving small cell lung ...

IDEAYA Biosciences, Inc.’s IDYA share price has surged by 10.70%, which has investors questioning if this is right time to sell.

BeiGene’s Tevimbra (tislelizumab) has been recommended by the European Medicines Agency’s human medicines committee as part of a first-line combination treatment for an aggressive form of lung cancer.

Cash and cash receivable balance of $20.9 million as of December 31, 2024, expected to fund operations, including clinical activities into 2027Strengthened cash position expected to support ...

Dukhi Hong, 84, has confounded medics to far exceed their six month prognosis following her diagnosis with small cell lung ...